Skip to toolbar
  • Log In
A Dose of Reality
Login
Skip to content
  • Home
  • Site-Wide Activity
  • Blog
  • Forums
  • Groups
  • Members
  • Resources

A Dose of Reality

Monoclonal antibody holds promise of reducing learning, memory …

January 26, 2016 by Jeremy Leave a reply

Chronic learning and memory problems that plague patients with schizophrenia may have a worthy foe in a monoclonal antibody that also holds promise in the fight against cancer and is already used to treat a rare disorder …

Follow this link: 

Monoclonal antibody holds promise of reducing learning, memory …

Share this:

  • Click to share on Pinterest (Opens in new window)
  • Click to share on Pocket (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Skype (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Like this:

Like Loading...

Related

Post navigation

← Ohio seeks to boost early childhood mental health services … We R Kids & Youth Mental Health | Eating Disorder Awareness … →

Copyright © 2021 A Dose of Reality  ·  Site by Jeremy Lawson

  • Home
  • Register
  • Resources
  • Privacy Policy
  • Terms of Service
  • Contact

@

Not recently active
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: